The ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) Network is a global network for infectious disease clinical studies. Our aim is to conduct rapid, cost-effective randomised controlled trials to deliver relevant and high quality evidence to guide clinical practice. We hope to achieve this vision through equity (shared ownership), sustainability (build long-term capacity and trust) and engagement of key stakeholders (including clinicians, scientists, governments, industry).
Company Details
- Employees
- 8
- Address
- 12 Science Drive 2, Tahir Foundation Building,singapore
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.advance-id.network/
- Keywords
- Singapore.
- HQ
- Singapore, Singapore
Advance-Id Network Questions
Advance-Id Network's website is https://www.advance-id.network/
Advance-Id Network's LinkedIn profile is https://sg.linkedin.com/company/advance-id
Advance-Id Network has
8 employees.
View email and phone details for 8
employees at Advance-Id Network.
Advance-Id Network's industry is
Research Services
Advance-Id Network's top competitors are
Tb-Cre Centre For Research Excellence In Tuberculosis Control,
Roche,
World Health Organization South-East Asia,
Health Sciences Authority,
World Mosquito Program (Wmp),
The Good Clinical Trials Collaborative,
Gender And Public Health Emergencies,
Icon Plc,
Aktyva,
Wellcome Trust.
Advance-Id Network's categories are Research Services
